Ready to Claim Your Credits?
You have attempts to pass this post-test. Take your time and review carefully before submitting.
Good luck!
Explore emerging findings from the FIND-CKD trial evaluating finerenone in patients with focal segmental glomerulosclerosis (FSGS), a challenging cause of chronic kidney disease. This brief video highlights key insights from the FSGS subgroup analysis and their potential relevance to kidney protection and disease progression. Gain expert perspectives on the clinical implications of these findings and their potential role in shaping future treatment approaches for patients with FSGS.
Global Learning Collaborative (GLC) designs and executes continuing education rooted in evidence-based medicine, clinical need, knowledge gap analysis, and careful consideration of learner feedback. Our mission is to serve as an inventive and relevant resource for clinical content and educational interventions across a broad spectrum of specialties. GLC’s methodology is founded on a commitment to continuing medical education and the innovative assessment of its effects on clinical practice. Our goal is clear—to develop and deliver the best education in the most impactful manner and to verify its results with progressive outcomes research.
This activity is supported by an independent educational grant from Bayer.
The views and opinions expressed in this educational activity are those of the faculty and do not necessarily represent the views of Medcon. This presentation is not intended to define an exclusive course of patient management; the participant should use his/her clinical judgment, knowledge, experience, and diagnostic skills in applying or adopting for professional use any of the information provided herein. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patients’ conditions and contraindications or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities. Links to other sites may be provided as additional sources of information.
Reproduction Prohibited
Reproduction of this material is not permitted without written permission from the copyright owner.
Explore emerging findings from the FIND-CKD trial evaluating finerenone in patients with focal segmental glomerulosclerosis (FSGS), a challenging cause of chronic kidney disease. This brief video highlights key insights from the FSGS subgroup analysis and their potential relevance to kidney protection and disease progression. Gain expert perspectives on the clinical implications of these findings and their potential role in shaping future treatment approaches for patients with FSGS.
Global Learning Collaborative (GLC) designs and executes continuing education rooted in evidence-based medicine, clinical need, knowledge gap analysis, and careful consideration of learner feedback. Our mission is to serve as an inventive and relevant resource for clinical content and educational interventions across a broad spectrum of specialties. GLC’s methodology is founded on a commitment to continuing medical education and the innovative assessment of its effects on clinical practice. Our goal is clear—to develop and deliver the best education in the most impactful manner and to verify its results with progressive outcomes research.
This activity is supported by an independent educational grant from Bayer.
The views and opinions expressed in this educational activity are those of the faculty and do not necessarily represent the views of Medcon. This presentation is not intended to define an exclusive course of patient management; the participant should use his/her clinical judgment, knowledge, experience, and diagnostic skills in applying or adopting for professional use any of the information provided herein. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patients’ conditions and contraindications or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities. Links to other sites may be provided as additional sources of information.
Reproduction Prohibited
Reproduction of this material is not permitted without written permission from the copyright owner.
We’re glad to see you’re enjoying ReachMD…
but how about a more personalized experience?
Stay current with the best on medical education
